v3.25.1
Stockholders' Equity
 3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Stockholders' Equity Stockholders' Equity
Below is a reconciliation of our common stock issued and outstanding:

Common Shares
Treasury Shares
Common Shares Outstanding
Shares as of December 31, 2024
443,399,772 (1,848,280)441,551,492 
Shares issued for the three months ended March 31, 2025
6,213,099 N/A6,213,099 
Shares forfeited for the three months ended March 31, 2025 (1)
(1,340,016)N/A(1,340,016)
Shares as of March 31, 2025
448,272,855 (1,848,280)446,424,575 
(1)Includes shares surrendered related to payroll tax withheld for the vested restricted shares.

Stock Repurchase Program

On April 30, 2024, our Board of Directors authorized a three-year stock repurchase program, (the "2024 Stock Repurchase Program"), under which the Company may repurchase up to 10.0 million shares of its common stock. Purchases may be made from time to time in the open market at prevailing prices or in privately negotiated transactions through April 30, 2027. The repurchase program does not obligate the Company to acquire any specific number of shares and may be suspended or terminated at any time. There was no share repurchase activity during the three months ended March 31, 2025. Subsequent to entering into the definitive agreement with Clearlake on March 23, 2025, the Company will not repurchase any shares under the 2024 Stock Repurchase Program.

Stockholder Dividends

The following dividends were declared by our Board of Directors and subsequently paid during the three months ended March 31, 2025:
Declaration DateRecord DatePayment DateDividends Per Share
February 6, 2025March 6, 2025March 20, 2025$0.05 
Dividends accrued for restricted shares are contingent and payable upon vesting of the underlying restricted shares.

Pursuant to the definitive agreement entered into with Clearlake on March 23, 2025, the Company has agreed not to declare or pay any dividend in respect of any shares. See Note 1 for additional details.